SIOUX FALLS, S.D., July 23, 2020 /PRNewswire/ — Sanford Health, the largest provider of rural healthcare in the country, today announced an $800,000 investment in TruGenomix, a veteran-owned precision behavioral health company.
As part of the strategic partnership, Sanford Health will support TruGenomix by providing its state-of-the-art lab and research capabilities to validate a first-to-market patented blood test for post-traumatic stress disorder (PTSD). The genomic test enables earlier identification and improves outcomes for high-risk populations, including veterans, active-duty service members, frontline health care workers, and first responders.
{iframe}https://www.prnewswire.com/news-releases/sanford-health-and-trugenomix-announce-partnership-to-commercialize-genomic-test-for-ptsd-301098461.html{/iframe}